The potential risk of mental health complications for instance psychosis or suicidality in supervised medical settings among the people who engage in research on psilocybin is small. Furthermore, research trials have not involved people who have schizophrenia or psychosis, as there is reasonable concern that psilocybin (or other psychedelics) On